Executive Sponsors


Supporting & Educational Partners

Alliance for Regenerative Medicine (ARM)
California Life Sciences Association (CLSA)
Cancer Research Institute CRI
Center for Biotechnology (CFB)
Journal of Immunotherapy and Precision Oncology (JIPO)
Society for Immunotherapy of Cancer (SITC)

Media Partners

Clinical trial vendors
Gene Therapy Net
Life Science Leader
MedTech Outlook

COVID-19 Statement

We remain committed to fulfilling our mission to present highly valuable programming to advance drug development and delivery for the benefit of patients. The safety and health of our community is absolutely our top priority. We are closely monitoring the CDC and other health authorities on the COVID-19 situation.

We hope to move forward with the fall events in-person. We are simultaneously planning for a virtual companion to the live events to accommodate attendees globally and a fully virtual back-up depending on the most up-to-date recommendations from health authorities.

With every in-person event, we will be implementing a number of changes to protect all attendees and our team from potential exposure to COVID-19 as best as possible. This begins with continuous monitoring of the COVID-19 situation, and adherence to health authority guidance and travel warnings.

Assuming we are COVID-19-safe to run in-person events beginning in late September, we will establish a no handshake culture, apply greater distance in seating and exhibitions, utilize pre-packaged registration packets with badges and individual lunches to avoid social density, wrapped snacks and no shared utensils, and make available plenty of hand sanitizers and face masks. Partnering meetings will require face masks and distance in seating.

As we prepare to roll out our post-pandemic plan, we will continue to keep the community informed. We are truly touched by the numerous messages of support from speakers, advisers, attendees and sponsors as we navigate and move forward together to serve patients.

In the meantime, our team continues to develop podcasts, articles and newsletters to share across all of our life science communities, while continuing its research to add even more choices to the upcoming events, including Patients as Partners, Mobile in Clinical Trials, DPharm, the Chief Medical Officer Summit, CRAACO, IO360 Combinations and PODD.